Asclera (polidocanol injection) is contraindicated for patients with known allergy (anaphylaxis) to polidocanol and patients with acute thromboembolic diseases.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 4/16/2010
Additional Asclera Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.